What do you get when you cross Court TV with the Food Channel? A recipe for a multi-million dollar jury verdict.
Drug giant Merck will not see such television programming, but it may have seen stars after getting hit with a $253-million jury award on Aug. 19. A product liability trial against its Cox-2 inhibitor drug Vioxx in Angleton, Texas, resulted in the quarter-billion dollar award, $229 million of which was for punitive damages.
Merck plans a vigorous appeal on multiple grounds and even pro-plaintiff observers concede that the award likely will drop to "only" $26 million, due to recent Texas tort reform caps on punitive damages.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
